FIELD: pharmaceutics.
SUBSTANCE: invention relates to a compound represented by the general formula (I)
(I)
wherein A represents, a phenyl ring, a thiophene ring, or an isothiazole ring; R1 is the same or different, and represents a halogen atom, or a C1-C3 alkyl group; R2 represents a hydrogen atom, or a C1-C6 alkyl group; p represents an integer of 0 to 5; V represents CR3 wherein R3 represents a hydrogen atom, amino group, nitro group, or a C1-C3 alkoxy group, or V represents a nitrogen atom; and X represents a halogen atom. Invention also relates to individual compounds, a receptor antagonist for LPA, a pharmaceutical composition.
EFFECT: new compounds having antagonistic activity in relation to the receptor for lysophosphatidic acid (LPA) have been obtained.
28 cl, 217 ex, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
HALOGEN-SUBSTITUTED HETEROCYCLIC COMPOUND | 2013 |
|
RU2756506C2 |
HALOGEN SUBSTITUTED HETEROCYCLIC COMPOUND SALT | 2015 |
|
RU2689315C2 |
HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2014 |
|
RU2681849C2 |
ALKALOID ESTER AND CARBAMATE DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF | 2012 |
|
RU2611627C2 |
PROLYL HYDROXYLASE INHIBITORS AND APPLICATION METHODS THEREOF | 2007 |
|
RU2429226C9 |
THIAZOLIDINEDIONE SALTS WITH REDUCED AFFINITY TO PPAR FOR TREATMENT OF METABOLIC DISORDERS | 2010 |
|
RU2564661C2 |
NOVEL POLYCYCLIC COMPOUNDS | 2006 |
|
RU2434006C2 |
TRIAZOLOPYRIDINES AS PHOSPHODIESTERASE INHIBITORS FOR TREATING SKIN DISEASES | 2009 |
|
RU2544011C2 |
ARYLALKYL ESTERS OF 4-AMINO-6-(SUBSTITUTED PHENYL)PICOLINATES AND 6-AMINO-2-(SUBSTITUTED PHENYL)-4-PYRIMIDINE CARBOXYLATES AND USE THEREOF AS HERBICIDES | 2012 |
|
RU2566760C2 |
CARBOSTYRIL COMPOUND | 2005 |
|
RU2430920C2 |
Authors
Dates
2018-04-03—Published
2013-12-27—Filed